Maravai LifeSciences Holdings (MRVI) Lifted Guidance, Is The Stock Still Cheap?

Simply Wall St.11-07

Maravai LifeSciences Holdings (MRVI) just tightened the spotlight on its 2026 outlook by lifting full year revenue guidance, while also reporting third quarter results that showed higher sales and a ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment